VEGFA and neoplasm: Considering the multitarget action of mCHT, biomarkers for angiogenesis inhibition, such as trombospondin-1, circulating VEGF and CEC, biomarkers expression of immune system enhancement, like TAM and TILs, and tumor burden have been explored in different studies.